Literature DB >> 2231341

Synthesis and antitumor activities of platinum complexes of unsymmetrical alicyclic diamines as carrier ligands.

K Morikawa1, M Honda, K Endoh, T Matsumoto, K Akamatsu, H Mitsui, M Koizumi.   

Abstract

The synthesis and biological activities of the platinum complexes of 2-aminomethylaziridine, 2-aminomethylazetidine, 2-aminomethylpyrrolidine, 2-aminomethylpiperidine as carrier ligands are described. The platinum complexes of 2-aminomethylazetidine and 2-aminomethylpyrrolidine are significantly effective against murine tumors. In particular, 2-aminomethylazetidine (1,1-cyclobutanedicarboxylato)platinum II (13) and 2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platin um II (16) exhibited potent antitumor activity and were soluble in water, and their antitumor activities against Colon 26 carcinoma (sc-ip system) were superior to CBDCA and comparable to CDDP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2231341     DOI: 10.1002/jps.2600790819

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.

Authors:  K Kamisango; T Matsumoto; K Akamatsu; K Morikawa; T Tashiro; K Koizumi
Journal:  Jpn J Cancer Res       Date:  1992-03

2.  Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.

Authors:  K Akamatsu; K Endo; T Matsumoto; K Kamisango; K Morikawa; M Koizumi; K Koizumi
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.